Purchase Order 36C26325P0588

Award Date 3/17/25
Potential Completion Date 3/18/25
Potential Value $34K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Minneapolis, MN 55417, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed

This is a firm fixed-price purchase order contract awarded by the U.S. Department of Veterans Affairs (VA) to Edwards Lifesciences LLC, a self-certified small disadvantaged business and limited liability company subsidiary of Edwards Lifesciences Corporation. The contract, with a ceiling value of $34,000.00, is for the provision of transcatheter aortic valve replacement (TAVR) products and related services to support healthcare services at VA facilities across the United States. The contract has an ultimate completion date of March 18, 2025. It is not associated with any set-aside designation. Edwards Lifesciences LLC has received numerous prime contract awards from the VA and Veterans Health Administration (VHA) to provide specialized cardiovascular devices and related services, including transcatheter heart valves, surgical implants, and prosthetics. The company also holds an active $1,590,000 Blanket Purchase Agreement with the VA-VHA to supply various Edwards valve products to the Veterans Integrated Service Network 21 through the end of 2028.

Generated 3/18/25, 10:00 AM